These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4897897)

  • 1. [Clinical studies on antinuclear factors (ANF)--incidence and titer of ANE in patients with a variety of diseases and serial observations of titer in patients with SLE and scleroderma].
    Nagasawa T; Shibata S; Nakao K
    Nihon Naika Gakkai Zasshi; 1969 May; 58(5):371-8. PubMed ID: 4897897
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the complement-fixing activity of antinuclear antibodies in lupus nephritis, mixed connective tissue disease, and scleroderma.
    Parker MD; Turner RA
    Arthritis Rheum; 1976; 19(5):857-61. PubMed ID: 786297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum antinuclear antibodies in progressive systemic sclerosis (scleroderma).
    Rothfield NF; Rodnan GP
    Arthritis Rheum; 1968 Oct; 11(5):607-17. PubMed ID: 4176069
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings: A simple immunofluorescence method for differentiation of ANF between RA and healthy persons and SLE and scleroderma patients.
    Stojan B
    Ann Rheum Dis; 1975 Apr; 34(2):197-8. PubMed ID: 1094966
    [No Abstract]   [Full Text] [Related]  

  • 5. The clinical significance of titered antinuclear antibodies.
    Ritchie RF
    Arthritis Rheum; 1967 Dec; 10(6):544-52. PubMed ID: 4864485
    [No Abstract]   [Full Text] [Related]  

  • 6. Two new antinuclear antibodies: their relationship to the homogeneous immunofluorescent pattern.
    Ritchie RF
    Arthritis Rheum; 1968 Feb; 11(1):37-43. PubMed ID: 4867854
    [No Abstract]   [Full Text] [Related]  

  • 7. [Differentiation with immunofluorescence of complement fixing and non-fixing antinuclear factors in patients with and without disseminated lupus erythematosus].
    Peltier AP
    Pathol Biol; 1968 Apr; 16(7):439-44. PubMed ID: 4882383
    [No Abstract]   [Full Text] [Related]  

  • 8. [Our experience in the study of nuclear and antinuclear constituant antibodies in rheumatology].
    Kahn MF; Dryll A; de Seze S
    J Belge Rhumatol Med Phys; 1967; 22(4):217-30. PubMed ID: 4185873
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance of antinuclear antibodies in overlap syndromes. I. Relationship between systemic lupus erythematosus, diffuse scleroderma and dermatomyositis].
    Zitnan D; Rovenský J; Cebecauer L; Hajzok O
    Fysiatr Revmatol Vestn; 1973 Jun; 51(3):152-7. PubMed ID: 4592583
    [No Abstract]   [Full Text] [Related]  

  • 10. [Demonstration of antinuclear antibodies in the epidermis of patients with progressive systemic sclerosis, generalized lupus erythematosus and dermatomyositis].
    Lamas Robles C; Mejía Arreguín S; Orozco Medina JH; González Mendoza A
    Rev Invest Clin; 1984; 36(2):115-9. PubMed ID: 6385174
    [No Abstract]   [Full Text] [Related]  

  • 11. [Detection of antinuclear antibodies using chicken erythrocytes in lupus erythematosus, scleroderma, rheumatoid arthritis and juvenile chronic arthritis].
    Lucić N; Bosković B
    Med Arh; 1985; 39(2-3):65-8. PubMed ID: 3917218
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy.
    Sharp GC; Irvin WS; LaRoque RL; Velez C; Daly V; Kaiser AD; Holman HR
    J Clin Invest; 1971 Feb; 50(2):350-9. PubMed ID: 4992992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-SS-A antibody and other antinuclear antibodies in systemic lupus erythematosus.
    Scopelitis E; Biundo JJ; Alspaugh MA
    Arthritis Rheum; 1980 Mar; 23(3):287-93. PubMed ID: 6965861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antinuclear autoantibodies in systemic diseases].
    Butov IuS
    Vestn Dermatol Venerol; 1980 Nov; (11):17-22. PubMed ID: 7003977
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serum antinuclear antibodies (in patients with visceral erythematodes, rheumatoid arthritis, progressive systemic sclerosis and discoid erythematodes)].
    Horvat Z
    Acta Med Iugosl; 1970; 24(3):229-40. PubMed ID: 4928076
    [No Abstract]   [Full Text] [Related]  

  • 16. Antinuclear antibodies in systemic lupus erythematosus. Detection with horseradish-peroxidase-conjugated antibody.
    Benson MD; Cohen AS
    Ann Intern Med; 1970 Dec; 73(6):943-9. PubMed ID: 4947942
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antinuclear, anticentromere and anti-ScL-70 antibodies in rheumatic diseases].
    Ivanova SM; Melkumova KL; Il'in KV; Riazantseva TA; Piven' VA; Speranskiĭ AI
    Lab Delo; 1990; (6):50-3. PubMed ID: 1699041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immune diagnosis of collagen diseases].
    Sönnichsen N
    Z Arztl Fortbild (Jena); 1981 Jun; 75(11-12):519-21. PubMed ID: 6975540
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary excretion of antinuclear antibodies.
    Meryhew NL; Messner RP; Tan EM
    J Rheumatol; 1983 Dec; 10(6):913-9. PubMed ID: 6363697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinuclear and anticytoplasmic antibodies. Concepts and misconceptions.
    Sontheimer RD; Deng JS; Gilliam JN
    J Am Acad Dermatol; 1983 Sep; 9(3):335-43. PubMed ID: 6415131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.